The company
Ardelyx, Inc.
ARDX · Nasdaq
ARDX stood above a rising 150-day average in 19 of the last 52 weekly readings, and has been out of that trend for the last 22 weeks. It is 38.9% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 22
- Industry in uptrend
- 15% -17 in 4 wk
- Insider buys, 12 months
- $3.9M
- Insider sales, 12 months
- $8.2M
- Officials’ trades on record
- 0
- Institutions holding
- 234 (+9)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 19 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| John E. BishopOfficer | sold | 17,281at $3.86 | 21 Aug 2026filed 25 Aug 2026 |
| John E. BishopOfficer | sold | 2,469at $3.86 | 21 Aug 2026filed 25 Aug 2026 |
| Michael RaabPresident & CEO | sold | 15,009at $3.86 | 21 Aug 2026filed 25 Aug 2026 |
| Michael RaabPresident & CEO | sold | 15,976at $3.86 | 21 Aug 2026filed 25 Aug 2026 |
| Michael RaabPresident & CEO | sold | 8,411at $3.86 | 21 Aug 2026filed 25 Aug 2026 |
| Michael RaabPresident & CEO | sold | 19,178at $3.86 | 21 Aug 2026filed 25 Aug 2026 |
| Laura A. WilliamsChief Patient Officer | sold | 3,486at $3.86 | 21 Aug 2026filed 25 Aug 2026 |
| Laura A. WilliamsChief Patient Officer | sold | 3,089at $3.86 | 21 Aug 2026filed 25 Aug 2026 |
| Laura A. WilliamsChief Patient Officer | sold | 2,430at $3.86 | 21 Aug 2026filed 25 Aug 2026 |
| Laura A. WilliamsChief Patient Officer | sold | 1,734at $3.86 | 21 Aug 2026filed 25 Aug 2026 |
| Mike KelliherChief Business Officer | sold | 3,104at $3.86 | 21 Aug 2026filed 25 Aug 2026 |
| Mike KelliherChief Business Officer | sold | 2,652at $3.86 | 21 Aug 2026filed 25 Aug 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| BlackRock, Inc.added · filed 7 Aug 2026 | 23,504,630$119.9M | +2,340,498+11.1% |
| Rubric Capital Management LPadded · filed 14 Aug 2026 | 16,202,700$82.6M | +14,341,804+770.7% |
| MILLENNIUM MANAGEMENT LLCreduced · filed 14 Aug 2026 | 13,900,773$70.9M | -3,941,597−22.1% |
| STATE STREET CORPreduced · filed 7 Aug 2026 | 13,356,128$68.1M | -248,179−1.8% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 10,471,494$53.4M | +105,982+1.0% |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC.added · filed 14 Aug 2026 | 9,546,732$48.7M | +1,377,363+16.9% |
| VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 2026 | 8,026,774$40.9M | +1,365,081+20.5% |
| GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026 | 6,401,736$32.7M | +394,281+6.6% |
| Jupiter Topco LLCnew · filed 14 Aug 2026 | 5,302,311$27.0M | +5,302,311 |
| TWO SIGMA INVESTMENTS, LPadded · filed 14 Aug 2026 | 5,209,823$26.6M | +935,780+21.9% |
News
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.